Business Wire

LEAPMOTOR

Share
Leapmotor's First Mass Production Model With CTC Technology

On February 25, 2022, Leapmotor for the first time announced the highlights of its new model C01. It is an electric mid-to-large-sized sedan developed on its C-Vehicle Platform, and also the first mass production model equipped with CTC battery technology, acceleration to 100 km/h in less than 4 seconds, 5-meter plus length and 700km ultra-long range. It will also further expand the portfolio with a planned launch in Q2 of 2022.

Technological and Natural Aesthetics to Create an Inner "Style"

Leapmotor C01 takes natural aesthetics as the design concept, emphasizing smart mobility experience. The design of C01 is featured with technical elements, offering a comfortable environment while the immersive cabin brings a luxurious experience for young, high-end, urban families.

C01 Key Product Features Unveiled

Because of Leapmotor's full-suite of R&D capabilities, the C01 offers compelling features – CTC technology, acceleration, vehicle length and NEDC range. It is set to become a popular product on the EV market.

NO.1 – Leapmotor’s First Mass Production Model with CTC Technology

CTC (Cell-To-Chassis) is a cutting-edge technology that integrates battery into the chassis, leading to greater shock resistance and improved strength of the vehicle. The C01 offers better handling performance, range and collision safety thanks to the CTC Technology.

0-100 km/h Acceleration in less than 4 seconds — Fastest acceleration among electric sedans within the same class in China, supercar-level performance

Leapmotor C01 has one of the fastest acceleration among electric sedans within the same class in China. It is equipped with "Higher Dimension" intelligent power system, using variable-structured oil-cooled electric drive with up to 1 million kilometers lifespan and the world's top NVH performance and power efficiency, meeting the demand for long range and high performance of EVs. In addition, flush door handle, sportback design, 0.226 ultra-low drag coefficient and 5% reduced vehicle weight will offer better performance.

Vehicle Length of over 5 Meter — Mid-to-large-sized sedan

As a mid-to-large sedan, Leapmotor C01 has a 5-meter plus length, wider rear legroom and large trunk space, offering exceptional comfort.

700km Ultra-long NEDC Range — Meeting long-distance travel needs

The C01 is equipped with a 90kWh ultra-large battery, capable of 700km ultra-long NEDC range, meeting consumer needs for long-distance travel. With penetrated large module scheme and intelligent battery management system can improve battery life, range and overall safety.

Full-suite of R&D capabilities Empowering Innovation

Leapmotor has been committed to growing its portfolio of R&D capabilities, obtaining and declaring 1,474 patents, 939 of which have been approved, and more than 40% of which are innovation patents.

Leapmotor increased its product line in 2021 by releasing the C11 as a mid-sized smart electric SUV, entering the RMB 150,000-200,000 SUV sector that has long been dominated by automakers.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press release

The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the depl

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press release

Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifoc

Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press release

Five-year contract to drive innovation in stimulation, intervention, digital and frac automationAgreement underscores gas as a pivotal fuel for global energy demand and a bridge to lower-carbon systems Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconve

Tabelog, Japan's Largest (*1)Restaurant Search and Reservation Service,Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press release

Experience Japan's Authentic Culinary Scene in Your Language — From Search to Reservation, All on Your SmartphoneRanked No. 1 in Downloads Among "Japanese Gourmet Search Apps" Chosen by International Travelers (*2) Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photo

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye